Literature DB >> 16442343

EEG in Creutzfeldt-Jakob disease.

Heinz Gregor Wieser1, Kaspar Schindler, Dominik Zumsteg.   

Abstract

Electroecenphalography (EEG) is an integral part of the diagnostic process in patients with Creutzfeldt-Jakob disease (CJD). The EEG has therefore been included in the World Health Organisation diagnostic classification criteria of CJD. In sporadic CJD (sCJD), the EEG exhibits characteristic changes depending on the stage of the disease, ranging from nonspecific findings such as diffuse slowing and frontal rhythmic delta activity (FIRDA) in early stages to disease-typical periodic sharp wave complexes (PSWC) in middle and late stages to areactive coma traces or even alpha coma in preterminal EEG recordings. PSWC, either lateralized (in earlier stages) or generalized, occur in about two-thirds of patients with sCJD, with a positive predictive value of 95%. PSWC occur in patients with methionine homozygosity and methionine/valine heterozygosity but only rarely in patients with valine homozygosity at codon 129 of the prion protein gene. PSWC tend to disappear during sleep and may be attenuated by sedative medication and external stimulation. Seizures are an uncommon finding, occurring in less than 15% of patients with sCJD. In patients with iatrogenic CJD, PSWC usually present with more regional EEG findings corresponding to the site of inoculation of the transmissible agent. In genetic CJD, PSWC in its typical form are uncommon, occurring in about 10%. No PSWC occur in EEG recordings of patients with variant CJD.

Entities:  

Mesh:

Year:  2006        PMID: 16442343     DOI: 10.1016/j.clinph.2005.12.007

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  54 in total

1.  The EEG in E200K familial CJD: relation to MRI patterns.

Authors:  Shmuel A Appel; Joab Chapman; Isak Prohovnik; Chen Hoffman; Oren S Cohen; Ilan Blatt
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

Review 2.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

Review 3.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  [Sporadic Creutzfeldt-Jakob disease imitates posterior reversible encephalopathy syndrome].

Authors:  Schulamith Krüger; Jörg Larsen; Jens Schaumberg
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

Review 5.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

Review 6.  Intravascular large B-cell lymphoma presenting clinically as rapidly progressive dementia.

Authors:  F M Brett; D Chen; T Loftus; Y Langan; S Looby; S Hutchinson
Journal:  Ir J Med Sci       Date:  2017-07-19       Impact factor: 1.568

7.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

8.  Prion gene paralogs are dispensable for early zebrafish development and have nonadditive roles in seizure susceptibility.

Authors:  Patricia L A Leighton; Richard Kanyo; Gavin J Neil; Niall M Pollock; W Ted Allison
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

9.  Progressive Stroke-Like Symptoms in a Patient with Sporadic Creutzfeldt-Jakob Disease.

Authors:  Jukka Lyytinen; Tiina Sairanen; Leena Valanne; Tapani Salmi; Anders Paetau; Eero Pekkonen
Journal:  Case Rep Neurol       Date:  2010-03-12

10.  Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease.

Authors:  Qi Shi; Xiu-Chun Zhang; Wei Zhou; Kang Xiao; Cao Chen; Hai-Yan Zhang; Jing-Yi Sun; Li-Na Chen; Xiao-Mei Zhang; Jun Han; Xiao-Ping Dong
Journal:  Prion       Date:  2015       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.